✦ LIBER ✦

“A La Carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding

✍ Scribed by Christophe Bureau; Jean-Marie Péron; Laurent Alric; Joséphine Morales; Jérôme Sanchez; Karl Barange; Jean-Louis Payen; Jean-Pierre Vinel

Book ID: 118686825
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 143 KB
Volume: 36
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2002.36945

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

“A la carte” treatment of portal hyperte

“A la carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding

✍ Christophe Bureau; Jean-Marie Péron; Laurent Alric; Joséphine Morales; Jérǒme Sa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

We report the results of adapting medical therapy to the monitoring of hemodynamic response in the prevention of a first variceal bleeding or rebleeding in patients with cirrhosis. Hepatic venous pressure gradient (HVPG) was measured before and after propranolol was initiated. The patients were cons

The Hemodynamic Response to Medical Trea

The Hemodynamic Response to Medical Treatment of Portal Hypertension as a Predictor of Clinical Effectiveness in the Primary Prophylaxis of Variceal Bleeding in Cirrhosis

✍ Carlo Merkel; Massimo Bolognesi; David Sacerdoti; Giancarlo Bombonato; Barbara B 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Hemodynamic assessment of pharmacologica

Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know

✍ Norman D Grace 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

Mechanical pumping of portal blood to th

Mechanical pumping of portal blood to the liver: hemodynamic effects of a new experimental treatment for portal hypertension

✍ Cristina Bemadich; Mercedes Fernández; Juan-Carlos Bandi; Jaume Bosch; Joan Rodé 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 660 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB